Document is current
Any future updates will be listed below
-
Authors
Mendes, Thiago Bosco https://orcid.org/0000-0001-8349-3303
Câmara-de-Souza, Alexandre Barbosa https://orcid.org/0000-0002-4029-3667
Halpern, Bruno https://orcid.org/0000-0003-0973-5065
- License Information
-
More Information
Article History
Received: 3 December 2021
Accepted: 18 February 2022
First Online: 4 March 2022
Declarations
:
: Not applicable.
: All authors consented in the publication after last revision.
: Bruno Halpern is on Advisory Board of Novo Nordisk, Eli_lilly and Astra Zeneca and received lecture fees from from Novo Nordisk, Eli Lilly, Boehringer-Ingelheim, Astra Zeneca, Takeda and Abbott Nutrition. Thiago Bosco Mendes and Alexandre Barbosa Câmara de Souza: none.
